Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases

A Arida, AD Protogerou, GD Kitas… - International journal of …, 2018 - mdpi.com
Patients with Chronic Inflammatory Rheumatic diseases (CIRD) are at increased risk of
cardiovascular disease (CVD), ascribed not only to classical risk factors, but also to the …

[PDF][PDF] One year in review 2016: pathogenesis of rheumatoid arthritis

E Bellucci, R Terenzi, GM La Paglia… - Clin Exp …, 2016 - academia.edu
Rheumatoid arthritis (RA) is an autoimmune disease characterised by chronic synovial
inlammation leading to joint destruction and bone erosions. Although the pathogenic …

Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α

P Aghagolzadeh, M Bachtler, R Bijarnia, C Jackson… - Atherosclerosis, 2016 - Elsevier
Background and aims Vascular calcification is prevalent in clinical states characterized by
low-grade chronic inflammation, such as chronic kidney disease (CKD). Calciprotein …

Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases

M Berger, P Fesler, C Roubille - Autoimmunity Reviews, 2021 - Elsevier
Background and objective Cardiovascular diseases (CVD) are the leading causes of death
in chronic inflammatory rheumatic diseases and are not solely explained by the increased …

Endothelial dysfunction in patients with rheumatoid arthritis: the role of hypertension

P Anyfanti, E Gavriilaki, S Douma… - Current Hypertension …, 2020 - Springer
Abstract Purpose of Review To review the data on the role of endothelial dysfunction and the
impact of hypertension as a potent mediator of cardiovascular disease in patients with …

Arterial stiffness as a surrogate marker of cardiovascular disease and atherosclerosis in patients with arthritides and connective tissue diseases: a literature review

K Triantafyllias, LE Thiele, L Cavagna, X Baraliakos… - Diagnostics, 2023 - mdpi.com
The increased cardiovascular (CV) risk among patients with autoimmune rheumatic
diseases, such as arthritides and connective tissue diseases, has been extensively …

[HTML][HTML] Lipoprotein (a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?

A Makris, F Barkas, PP Sfikakis, E Liberopoulos… - Atherosclerosis …, 2023 - Elsevier
Background and aims Lipoprotein (a)[Lp (a)] and interleuking-6 (IL-6), an inflammation
biomarker, have been established as distinct targets of the residual atherosclerotic …

Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities

A Arida, AD Protogerou, G Konstantonis… - …, 2017 - academic.oup.com
Objectives. RA associates with increased cardiovascular disease (CVD) morbidity and
mortality due to accelerated atherosclerosis, attributed to both classical risk factors and …

Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity

M Biskup, W Biskup, M Majdan… - Rheumatology …, 2018 - Springer
Systemic inflammation and disease activity seem to contribute to excessive prevalence of
cardiovascular (CV) diseases (CVDs) in patients with rheumatoid arthritis (RA). The …

PCSK9/LDLR system and rheumatoid arthritis-related atherosclerosis

A Arida, AI Legaki, E Kravvariti, A Protogerou… - Frontiers in …, 2021 - frontiersin.org
Background/Aims: Rheumatoid arthritis (RA) is associated with the emergence of
cardiovascular disease, while chronic inflammation is considered a common denominator …